Correction to: European Journal of Drug Metabolism and Pharmacokinetics (2021) 46:277–287 10.1007/s13318-020-00669-7
The original version of this article unfortunately contained a few errors. The correct information is given below:
Page 281, 1st paragraph, 2nd sentence, which previously read:
The serum samples in TR02-112 were clustered in two primary windows—0–4 h and 12–24 h postdose (Fig. 1).
Should read:
The serum samples in TR02-112 were clustered in two primary windows—0–4 h and 12–24 h postdose (Fig. 2).
Figure 2: The 24- and 48-hour labels on the x-axis in Figure 2 were transposed. The corrected version of Fig. 2 is given below:
Figure 2.
Observed serum amikacin concentration versus time sinces last dose. Closed and open circles represent individual values for patients in CONVERT and TR02-112 studies, respectively. Amikacin concentrations that were BLQ are shown at LLOQ (i.e., 0.15 mg/L). One BLQ concentration in the TR02-112 study, observed at > 500 h after the previous dose, was excluded; it was retained in the population pharmacokinetic dataset but did not impact the model fit. BLQ below the limit of quantification; LLOQ lower limit of quantification
The corrected version of supplementary file is updated here.
Supplementary Information
Below is the link to the electronic supplementary material.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.